Just saw that Allurion got FDA approval for their gastric balloon system and honestly the product concept is pretty wild. So basically you swallow this smart capsule during a quick office visit, it fills up with fluid in your stomach and stays there for four months making you feel full. Then it just opens up and passes naturally - no surgery needed. That's actually clever engineering for people dealing with weight issues who want something less invasive than surgery. Stock jumped 57% to $1.71 on the news, which makes sense given how much of a gap this fills in the market. The gastric balloon approach seems way more accessible than traditional bariatric procedures. Dr. Jaime Ponce from the Weight Loss Center of Chattanooga basically said this gastric balloon could be a solid middle ground for patients with BMI 30-40 who aren't ready for surgery or want to avoid long-term medications. Their AUDACITY trial data supposedly backs up the safety and efficacy claims. Not gonna lie, if this actually works as advertised it could be a game-changer for medical device companies tackling obesity. The stock's trading range over the past year was $0.95 to $4.18, so today's move is pretty significant. Curious if this gastric balloon momentum holds or if it's just the initial FDA approval pop.